Nagendran Sukumar
Transaction: 07/10/2026
SELL
Change
-200,000
Price
$6.24
Filing
07/10/2026
Type
SELL
Taysha Gene Therapies, Inc.
TSHA • Biotechnology
$5.60
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.07B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.07Healthy liquidity · 12.23Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:08 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.60
Change0.00%
Shares Out369.04M
Market Cap$2.07B
Enterprise Value$1.62B
52W Range2.71 - 7.30
Beta1.19
P/E-13.81
P/S376.78
P/B5.34
P/FCF-15.59
EV/Sales294.90
Price$5.60
Change0.00%
Shares Out369.04M
Market Cap$2.07B
Enterprise Value$1.62B
52W Range2.71 - 7.30
Beta1.19
P/E-13.81
P/S376.78
P/B5.34
P/FCF-15.59
EV/Sales294.90
EV/EBITDA-10.79
EV/FCF-12.20
Earnings Yield-7.24%
FCF Yield-6.41%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-11.31%
Profit Margin-11.15%
Debt/Eq0.07
Current Ratio12.23
Quick Ratio12.23
Target$14.00
Target Upside150.00%
Target Median$14.00
Target Range13.00 - 15.00
Volume3.91M
Avg Volume2.96M
EPS Surprise-0.02
Investment DNA
How strong this company looks for long-term investors
31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
32/100
Why this score▼
Manageable debt level · 0.07Healthy liquidity · 12.23Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 18 analyst votes · 2026-09-04
92/100
Bullish
Bullish
15
Hold
3
Bearish
0
Price Target
2026-08-13
Low
$13.00
Mean
$14.00
Median
$14.00
High
$15.00
Insider Transactions
Recent executive and insider activity
⚠ 5 high-volume insider sells detected
Sepp-Lorenzino Laura
Transaction: 06/01/2026
BUY
Change
+42,671
Price
$5.97
Filing
06/02/2026
Type
BUY
Sepp-Lorenzino Laura
Transaction: 06/01/2026
BUY
Change
+21,335
Price
Not reported
Filing
06/02/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Nagendran Sukumar | SELL | -200,000 | $6.24 | 07/10/2026 | 07/10/2026 |
| Sepp-Lorenzino Laura | BUY | +42,671 | $5.97 | 06/01/2026 | 06/02/2026 |
| Sepp-Lorenzino Laura | BUY | +21,335 | Not reported | 06/01/2026 | 06/02/2026 |
| Long Alison S | BUY | +42,671 | $5.97 | 06/01/2026 | 06/02/2026 |
| Long Alison S | BUY | +21,335 | Not reported | 06/01/2026 | 06/02/2026 |
| Donenberg Phillip B. | BUY | +42,671 | $5.97 | 06/01/2026 | 06/02/2026 |
| Donenberg Phillip B. | BUY | +21,335 | Not reported | 06/01/2026 | 06/02/2026 |
| Stalfort John A III | BUY | +42,671 | $5.97 | 06/01/2026 | 06/02/2026 |
| Stalfort John A III | BUY | +21,335 | Not reported | 06/01/2026 | 06/02/2026 |
| Nagendran Sukumar | SELL | -19,021 | $1.71 | 04/10/2026 | 04/13/2026 |
| Nagendran Sukumar | SELL | -200,000 | $4.46 | 04/10/2026 | 04/13/2026 |
| Alam Kamran | SELL | -1,655 | $4.52 | 02/04/2026 | 02/06/2026 |
| Alam Kamran | SELL | -23,849 | $4.61 | 01/26/2026 | 01/27/2026 |
| Nolan Sean P. | SELL | -41,312 | $4.61 | 01/26/2026 | 01/27/2026 |
| Nagendran Sukumar | SELL | -26,918 | $4.61 | 01/26/2026 | 01/27/2026 |
| Alam Kamran | SELL | -78,968 | $4.75 | 01/23/2026 | 01/27/2026 |
| Nolan Sean P. | SELL | -136,789 | $4.75 | 01/23/2026 | 01/27/2026 |
| Nagendran Sukumar | SELL | -89,132 | $4.75 | 01/23/2026 | 01/27/2026 |
| Nagendran Sukumar | SELL | -111,324 | $0.70 | 01/12/2026 | 01/14/2026 |
| Nagendran Sukumar | SELL | -200,000 | $4.71 | 01/12/2026 | 01/14/2026 |